Treating pulmonary arterial hypertension: Cautious hope in a deadly disease

Omar A. Minai, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Marie M. Budev, DO, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: Omar A. Minai, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: minaio@ccf.org

Dr. Minai has disclosed that he has received honoraria from the Actelion, Encysive, Gilead, Pfizer, and United Therapeutics corporations for consulting and speaking.

Omar A. Minai, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Marie M. Budev, DO, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: Omar A. Minai, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: minaio@ccf.org

Dr. Minai has disclosed that he has received honoraria from the Actelion, Encysive, Gilead, Pfizer, and United Therapeutics corporations for consulting and speaking.

Omar A. Minai, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Marie M. Budev, DO, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Address: Omar A. Minai, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: minaio@ccf.org

Dr. Minai has disclosed that he has received honoraria from the Actelion, Encysive, Gilead, Pfizer, and United Therapeutics corporations for consulting and speaking.